Saturday November 21 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

Zymeworks

Zymeworks, a private Canadian company, was founded in the fall of 2003 by Dr. Ali Tehrani and Mr. Anthony Fejes M.Sc. with the help of Mr. Haig Farris, Mr. Nick Bedford and Dr. Andrew Wright. Following the closing of an initial round of financing and support from the National Research Council's Industrial Research Assistance Program (NRC-IRAP), the company began operation in early 2004.VisionBy combining novel ideas with advances in life science research and computational technology, Zymeworks' vision is to become a world-class leader in molecular modeling and industrial enzyme engineering.Zymeworks' phased business model involves leveraging the company's expertise and technology in molecular modeling, while pursuing its own enzyme engineering goals.Mission
To research, develop and provide highly customized biocatalysts (enzymes) that enable our customers to lower manufacturing costs, energy requirements and environmental impact To pioneer and commercialize new bio-processing technologies as an alternative to traditional chemical-based manufacturing practices
Science & TechnologyThe foundation of Zymeworks' technology is a collection of innovative and proprietary ideas that advance the science of molecular modeling. This field is concerned with the use of computational resources to simulate and analyze the physical and chemical properties of complex molecular structures. Scientists in both academia and industry are increasingly turning to molecular modeling as an effective predictive tool for optimized lead generation and reduced "wet-lab" experimentation. This is particularly becoming the case with respect to enzyme engineering and drug design.


Contact Details:
201-1401 W Broadway
Vancouver,
British Columbia
V6H 1H6
Canada
Tel:(604) 678-1388
Fax:(604) 737-7077
Email:info@zymeworks.com
WWW:

www.zymeworks.com/




Loading...

Recent Publications by Zymeworks:

A systematic molecular dynamics study of nearest-neighbor effects on base pair and base pair step conformations and fluctuations in B-DNA.
It is well recognized that base sequence exerts a significant influence on...
24th October, 2009
Institut de Biologie et Chimie des Proteines, CNRS UMR 5086/Universite de Nucleic Acids Res. 2009 Nov 6.
DOI Direct Link

BioNews Results for Zymeworks:

LifeSciences British Columbia Elects Two Industry Leaders to their Board of Directors
Genetic Engineering News:  Oct 14 2009 2:49PM Matching: zymeworks
Zymeworks Appoints Computational Antibody Design Expert Dr. Bruce Tidor to its Scientific Advisory Board
Pharma Live:  Oct 3 2009 12:35AM Matching: zymeworks

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 664 times since April 2007, the link to the organisation's website has been followed 90 times

Recent Search Terms used to find this page: zymeworks company profile | zymeworks | Zymeworks email | NRC Zymeworks | zymeworks | zymeworks, job, canada,2009 | Andrew Wright zymeworks | zymework | enzyme engineering companies | Zymeworks | .

Search for more companies in Vancouver,

Search for more companies in British Columbia



This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Zymeworks

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.